Teva-Triamterene/HCTZ (2020-07-24)

Starting date:
July 24, 2020
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-73637

Last updated:

Summary

  • Product: Teva-Triamterene/HCTZ

Reason

The assay for Triamterene is out of specification in the affected lot and the assay for Hydrochlorothiazide (HCTZ) is out of trend in the affected lot.

Alternate Brand Names: Maxzide, Dyazide, Dyrenium

Depth of distribution

Wholesalers, Retailers

Affected products

Teva-Triamterene/HCTZ

DIN, NPN, DIN-HIM

DIN 00532657

Dosage form

Tablet

Strength

Triamterene 50mg and Hydrochlorothiazide 25mg

Lot or serial number

35360453A

Companies

Recalling Firm
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA